Skip to main content

Cancer Research Publications

KARIM BOUDADI

  1. Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.
    Boudadi K, Suzman DL, Anagnostou V, Fu W, Luber B, Wang H, Niknafs N, White JR, Silberstein JL, Sullivan R, Dowling D, Harb R, Nirschl TR, Veeneman BA, Tomlins SA, Wang Y, Jendrisak A, Graf RP, Dittamore R, Carducci MA, Eisenberger MA, Haffner MC, Meeker AK, Eshleman JR, Luo J, Velculescu VE, Drake CG, Antonarakis ES.
    Oncotarget. 2018 Jun 19;9(47):28561-28571. doi: 10.18632/oncotarget.25564. eCollection 2018 Jun 19.

STEPHEN R BRODERICK

  1. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
    Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, Marrone KA, Verde F, Guo H, Zhang J, Caushi JX, Chan HY, Sidhom JW, Scharpf RB, White J, Gabrielson E, Wang H, Rosner GL, Rusch V, Wolchok JD, Merghoub T, Taube JM, Velculescu VE, Topalian SL, Brahmer JR, Pardoll DM.
    PMID:29658848 PMCID:PMC6223617. The New England Journal of Medicine 16 Apr 2018, 378(21):1976-1986
  2. Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer.
    Samson P, Puri V, Broderick S, Patterson GA, Meyers B, Crabtree T.
    Ann Thorac Surg. 2017 Apr;103(4):1101-1108. doi: 10.1016/j.athoracsur.2016.09.032. Epub 2017 Jan 18.

CURTILAND DEVILLE, JR

  1. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.
  2. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Eur Urol. 2019 Apr 13. pii: S0302-2838(19)30208-8. doi: 10.1016/j.eururo.2019.03.022.
  3. Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.
    Deville C Jr, Jain A, Hwang WT, Woodhouse KD, Both S, Wang S, Gabriel PE, Christodouleas JP, Bekelman J, Tochner Z, Vapiwala N.
    Acta Oncol. 2018 Nov;57(11):1506-1514. doi: 10.1080/0284186X.2018.1487583. Epub 2018 Jul 20.

THEODORE LESLIE DEWEESE

  1. Needs and Challenges for Radiation Oncology in the Era of Precision Medicine.
    Quon H, McNutt T, Lee J, Bowers M, Jiang W, Lakshminarayanan P, Cheng Z, Han P, Hui X, Shah V, Moore J, Nakatsugawa M, Robertson S, Cecil E, Page B, Kiess A, Wong J, DeWeese T.
    Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):809-817. doi: 10.1016/j.ijrobp.2018.11.017. Epub 2018 Dec 15.
  2. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.
  3. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Eur Urol. 2019 Apr 13. pii: S0302-2838(19)30208-8. doi: 10.1016/j.eururo.2019.03.022.

KHALED MAHMOUD EL-SHAMI

  1. A rare breed: Wild-type braf and ighv expression in a 29 year old lady with classical hairy cell leukemia.
    Hossain A, Rafei H, Jariwala A, El-Shami K.
    Leuk Res Rep. 2017 Jan 24;7:20-22. doi: 10.1016/j.lrr.2017.01.001. eCollection 2017.

JONATHAN AGNER FORSBERG

  1. Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?
    Nandra R, Parry M, Forsberg J, Grimer R.
    Clin Orthop Relat Res. 2017 Jun;475(6):1681-1689. doi: 10.1007/s11999-017-5346-1. Epub 2017 Apr 10.
  2. Preclosure spectroscopic differences between healed and dehisced traumatic wounds
    Radowsky JS, Neely R, Forsberg JA, Lisboa FA, Dente CJ, Elster EA, Crane NJ.
    PLoS One. 2018 Sep 27;13(9):e0204453. doi: 10.1371/journal.pone.0204453. eCollection 2018.

STEPHEN C GRECO

  1. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):883-888. doi: 10.1016/j.ijrobp.2018.03.060. Epub 2018 Apr 5.
  2. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis
    Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C Jr, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU.
    Eur Urol. 2019 Apr 13. pii: S0302-2838(19)30208-8. doi: 10.1016/j.eururo.2019.03.022.

MATTHEW LADRA

  1. A Road Map for Important Centers of Growth in the Pediatric Skeleton to Consider During Radiation Therapy and Associated Clinical Correlates of Radiation-Induced Growth Toxicity.
    Rao AD, Ladra M, Dunn E, Kumar R, Rao SS, Sehgal S, Dorafshar AH, Morris CD, Terezakis SA.
    Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):669-679. doi: 10.1016/j.ijrobp.2018.10.026. Epub 2018 Nov 7.
  2. Socioeconomic factors affect the selection of proton radiation therapy for children.
    Shen CJ, Hu C, Ladra MM, Narang AK, Pollack CE, Terezakis SA.
    Cancer. 2017 Oct 15;123(20):4048-4056. doi: 10.1002/cncr.30849. Epub 2017 Jun 27.

ANDREW DANIEL LERNER

  1. Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
    Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J.
    J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26.

BENJAMIN PHILIP LEVY

  1. Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
    Caroline E. McCoach, Collin M. Blakely, Kimberly C. Banks, Benjamin Levy, Ben M. Chue, Victoria M. Raymond, Anh T. Le, Christine E. Lee, Joseph Diaz, Saiama N. Waqar, William T. Purcell, Dara L. Aisner, Kurtis D. Davies, Richard B. Lanman, Alice T. Shaw and Robert C. Doebele.
    DOI: 10.1158/1078-0432.CCR-17-2588 Published June 2018.
  2. Afatinib with Pembrolizumab for Treatment of Patients with Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol
    Levy B, Paz-Ares L, Bennouna J, Felip E, Abreu DR, Isla D, Barlesi F, Molinier O, Madelaine J, Audigier-Valette C, Kim SW, Kim HR, Ozguroglu M, Erman M, Badin FB, Mekhail TM, Scheff R, Chisamore MJ, Sadrolhefazi B, Riess JW.
    Clin Lung Cancer. 2019 May;20(3):e407-e412. doi: 10.1016/j.cllc.2018.12.022. Epub 2019 Jan 4.

BRANDI PAGE

  1. Needs and Challenges for Radiation Oncology in the Era of Precision Medicine.
    Quon H, McNutt T, Lee J, Bowers M, Jiang W, Lakshminarayanan P, Cheng Z, Han P, Hui X, Shah V, Moore J, Nakatsugawa M, Robertson S, Cecil E, Page B, Kiess A, Wong J, DeWeese T.
    Int J Radiat Oncol Biol Phys. 2019 Mar 15;103(4):809-817. doi: 10.1016/j.ijrobp.2018.11.017. Epub 2018 Dec 15.
  2. Barriers to radiotherapy access at the University College Hospital in Ibadan, Nigeria.
    Anakwenze CP Ntekim A Trock B, Uwadiae IB, Page BR.
    Clin Transl Radiat Oncol. 2017 Jun 21;5:1-5. doi: 10.1016/j.ctro.2017.05.003. eCollection 2017 Aug.
  3. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.
    Schmitt N, Page BR.
    Int J Audiol. 2018 Sep;57(sup4):S49-S54. doi: 10.1080/14992027.2017.1353710. Epub 2017 Jul 20.

CHANNING JUDITH PALLER

  1. Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
    Gina Nauman, Javaughn Corey Gray, Rose Parkinson, Mark Levine, Channing J. Paller.
    Antioxidants 2018, 7(7), 89; doi: 10.3390/antiox7070089.

LEENA TARIQ RAHMAT

  1. The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia
    Rahmat L, Damon L.
    Case Reports in Hematology; Volume 2018, Article ID 7267920, 3 pages. https://doi.org/10.1155/2018/7267920.

NICOLE SCHMITT

  1. Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.
    Schmitt N, Page BR.
    Int J Audiol. 2018 Sep;57(sup4):S49-S54. doi: 10.1080/14992027.2017.1353710. Epub 2017 Jul 20.

AKILA VISWANATHAN

  1. Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer.
    Ma TM, Harkenrider MM, Yashar CM, Viswanathan AN, Mayadev JS.
    Brachytherapy. 2019 Feb 2. pii: S1538-4721(18)30566-X. doi: 10.1016/j.brachy.2018.12.002. [Epub ahead of print]

JEAN WRIGHT

  1. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.
    Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL, Jagsi R.
    Pract Radiat Oncol. 2018 May - Jun;8(3):145-152. doi: 10.1016/j.prro.2018.01.012. Epub 2018 Mar 12.

Connect with Sibley Hospital

Connect with Surburban Hospital

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Powered by the BroadcastMed Network